MORISON INDUSTRIES PLC.- QUARTER 2 - FINANCIAL STATEMENT FOR 2026
Eye captured this official filing and document processing is still underway.
Please wait
Open
N/A
Previous close
₦10.40
Day range
N/A
Volume
4,353
2205.4x P/E
Awaiting filing
No current yield
65/100 measured
Moderate liquidity
MORISON has a heavy downside risk over 30 days and heavy downside risk over one year.
7-day forecast is free
You can use the full 7-day forecast on the free plan. Upgrade to Pro to unlock the 30-day and 1-year views.
Expected move
-4.51%
Expected price
₦9.93
Lower path
₦9.55
Upper path
₦10.31
Confidence
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
This official filing has been discovered and is awaiting full extraction or review.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
This official filing has been discovered and is awaiting full extraction or review.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
Whisone Eye extracted this official filing. Open the source to review the complete disclosure.
This official filing has been discovered and is awaiting full extraction or review.
Director dealings
0
Reported buys, sells, and mixed dealings.
Official filings
11
Financial reports and company disclosures captured by Eye.
Market events
0
Insider, filing, dividend, and price events.
Source records
41
Captured updates we can trace.
Whisone is bearish because the bullish case is not yet strong enough to lead while fundamentals are weak at 33/100. Whisone has low conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Sentiment
Market mood from flow, events, and attention.
ROE
0.6%
Return on equity
ROA
0.9%
Return on assets
Debt / equity
0.17
Lower is usually safer.
P/B ratio
10.68
Useful for book value support.
75/100
Direction
Cautious
Main supports
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Liquidity looks thin, so even a good thesis may take longer to show up in price.
Fair value
₦0.11
Analyst view
n/a
Forecast refresh
Updated 47 min ago
Quality score
41
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
4.0
Momentum is weak and the stock is in oversold territory.
Recent trend
Sideways
+0.0% across the latest saved price window.
Volatility
Low
Beta is 0.46. Price has historically moved more calmly than the wider market.
52-week position
71% of range
Price is sitting around the middle of its 52-week range.
Volume confirmation
0.31x average
Trading activity is light, so the current price move has weaker confirmation.
local_manufacturing_and_access
MORISON may also move because the HEALTHCARE sector may benefit from local_manufacturing_and_access. Confidence 56%.
MeCure's emphasis on affordable, locally manufactured medicines and wider market penetration illustrates sector-level support for improved local manufacturing and access to quality medicines.
manufacturing infrastructure
MORISON may also move because the HEALTHCARE sector may benefit from manufacturing infrastructure. Confidence 56%.
Completion of a pharmaceutical manufacturing facility by Neimeth increases manufacturing capacity in the healthcare sector.
local_manufacturing_and_product_innovation
MORISON may also move because the HEALTHCARE sector may move with local_manufacturing_and_product_innovation. Confidence 53%.
MeCure's focus on deepening local manufacturing, product innovation, and expanded market penetration reflects sector-wide themes of local production and access to affordable medicines.
profit-taking
MORISON may also move because the HEALTHCARE sector may move with profit-taking. Confidence 53%.
Profit-taking is identified in the article as a trigger for the sell-off impacting SWOOT stocks.
increased manufacturing capacity
MORISON may also move because the HEALTHCARE sector may benefit from increased manufacturing capacity. Confidence 53%.
Neimeth's expansion and completion of a pharmaceutical manufacturing facility will increase production capacity within the healthcare sector.
Halal certification adoption
MORISON may also move because the HEALTHCARE sector may benefit from halal certification adoption. Confidence 49%.
Halal certification can increase consumer confidence and market access where Halal-compliant products are important, supporting sector trust and accessibility.
MORISON
Morison Industries Plc
Price: ₦10.40
P/E: 2205.37
Yield: N/A
EKOCORP
Eko Corporation Plc
Price: ₦5.80
P/E: N/A
Yield: N/A
FIDSON
Fidson Healthcare Plc
Price: ₦93.55
P/E: 22.27
Yield: 1.6%
MAYBAKER
May & Baker Nigeria Plc
Price: ₦40.00
P/E: 12.66
Yield: 1.0%
Industry
Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
Founded
1955
Employees
26
Exchange
NGX
Ticker
MORISON